Updates

13th invitation to manufacturers for Expression of Interest (EOI) regarding ERP process

23 Oct 2017

13th invitation to manufacturers for Expression of Interest (EOI) regarding ERP process was published on October 2017.

Product of interest: Benzathine benzylpenicillin 2.4 million units per dose in vial for reconstitution and intramuscular Injection.

For more information: https://www.ungm.org/Public/Notice/63112.

We use cookies and other identifiers to help improve your online experience. By using our website you agree to this. To learn more, including how to change your settings, see our cookie policy

X